VELSIPITY has demonstrated safety data in clinical trials

VELSIPITY should not be taken by patients with certain cardiac conditions such as prior heart attack, chest pain, stroke or heart failure. VELSIPITY can cause serious side effects including infections (some life threatening), a slow heart rate known as bradyarrhythmia, liver problems, increased blood pressure, a vision problem called macular edema, certain types of skin cancer, swelling and narrowing of the blood vessels in your brain, or shortness of breath. See full Important Safety Information at the bottom of this page.

style

section-heading, spacing-vertical-lg

The safety of VELSIPITY has been studied in a clinical program with 577 participants across 3 placebo-controlled studies.

The most common side effects occurring in ≥5% of subjects taking VELSIPITY were headache, elevated liver tests, and dizziness.

Your doctor will talk to you about the possibility of side effects, potential for serious infections, and whether VELSIPITY is appropriate for you.

Across two 12-week studies, 6% of people taking VELSIPITY discontinued due to side effects and 4% of people taking VELSIPITY discontinued in the 1-year study.

Learn more about VELSIPITY

Discover The VELSIPITY Journey

/global/sign-up-banner